Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

著者: Jo Hardy, Christina Baggott, James Fingleton, Helen K. Reddel, Robert J. Hancox, Matire Harwood, Andrew Corin, Jenny Sparks, Daniela Hall, Doñah Sabbagh, Saras Mane, Alexandra Vohlidkova, John Martindale, Mathew Williams, Philippa Shirtcliffe, Mark Holliday, Mark Weatherall, Richard Beasley, Andrew Corin, Liz Dronfield, Colin Helm, Tracy Paterson, Bhuwan Poudel, Malcolm Dyer, Christine Jasinski, Davitt Sheahan, Pamela Sheahan, Nick Gailer, Jan Van Zuilen, Andy Basa, Christine Devereaux, Karin Egan, S. Mulhern Haughey, Rodney Marks, Dirk Venter, Hank Zhang, Karen Trevithick, Mike Williams, Philippa Williams, Christina Baggott, Richard Beasley, Irene Braithwaite, Alexandra Eathorne, Stefan Ebmeier, James Fingleton, Daniela Hall, Jo Hardy, Matire Harwood, Mark Holliday, Claire Houghton, Saras Mane, John Martindale, Karen Oldfield, Janine Pilcher, Doñah Sabbagh, Philippa Shirtcliffe, Suzanne Snively, Jenny Sparks, Alexandra Vohlidkova, Mathew Williams, Patrick Collins, Summer Hassan, Annika Lam, Claudette Lionnet, Barney Montgomery, Liz Smaill, Stella Moon, Dean Quinn, Elena Bayly-McCredie, Chris Millar-Coote, Dean Millar-Coote, Jim Reid, Anna Samuel, Nicola W. Burton, Tina Mullard, Tyronne Tranquilino, Edward Watson, Jill Bell, Rachel Harris, John C. Richmond, Sue Smith, Brent Krivan, Cheryl Robertson, Robert J. Hancox, Mark Weatherall, Sue Glensor, Dermot O'Connor, Anne-Christine Porrachia, Helen K. Reddel - The Lancet 2019 被引用: 276